DK175032B1 - Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat - Google Patents

Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat Download PDF

Info

Publication number
DK175032B1
DK175032B1 DK198706807A DK680787A DK175032B1 DK 175032 B1 DK175032 B1 DK 175032B1 DK 198706807 A DK198706807 A DK 198706807A DK 680787 A DK680787 A DK 680787A DK 175032 B1 DK175032 B1 DK 175032B1
Authority
DK
Denmark
Prior art keywords
solution
nasal
disorder
sodium
conjunctivitis
Prior art date
Application number
DK198706807A
Other languages
Danish (da)
English (en)
Other versions
DK680787A (da
DK680787D0 (da
Inventor
Andrew Reginald Clark
Paul Wright
Julia Helena Ratcliffe
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630769A external-priority patent/GB8630769D0/en
Priority claimed from GB868630767A external-priority patent/GB8630767D0/en
Priority claimed from GB868630904A external-priority patent/GB8630904D0/en
Priority claimed from GB878706684A external-priority patent/GB8706684D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of DK680787D0 publication Critical patent/DK680787D0/da
Publication of DK680787A publication Critical patent/DK680787A/da
Application granted granted Critical
Publication of DK175032B1 publication Critical patent/DK175032B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK198706807A 1986-12-23 1987-12-22 Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat DK175032B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB868630769A GB8630769D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB868630767A GB8630767D0 (en) 1986-12-23 1986-12-23 Pharmaceutical formulation
GB8630769 1986-12-23
GB8630767 1986-12-23
GB8630904 1986-12-24
GB868630904A GB8630904D0 (en) 1986-12-24 1986-12-24 Pharmaceutical formulation
GB878706684A GB8706684D0 (en) 1987-03-20 1987-03-20 Pharmaceutical formulation
GB8706684 1987-03-20

Publications (3)

Publication Number Publication Date
DK680787D0 DK680787D0 (da) 1987-12-22
DK680787A DK680787A (da) 1988-06-24
DK175032B1 true DK175032B1 (da) 2004-05-03

Family

ID=27449862

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706807A DK175032B1 (da) 1986-12-23 1987-12-22 Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat

Country Status (22)

Country Link
US (1) US5443833A (fr)
EP (1) EP0279121B1 (fr)
JP (2) JP2568233B2 (fr)
KR (1) KR960001370B1 (fr)
AU (1) AU595969B2 (fr)
BE (2) BE1002179A5 (fr)
CA (1) CA1296635C (fr)
CH (1) CH674937A5 (fr)
DE (1) DE3787274T2 (fr)
DK (1) DK175032B1 (fr)
ES (1) ES2058129T3 (fr)
FI (1) FI875616A (fr)
FR (1) FR2609392B1 (fr)
GR (1) GR871999B (fr)
IE (3) IE940371L (fr)
IL (1) IL84893A (fr)
LU (1) LU87087A1 (fr)
MY (1) MY101535A (fr)
NO (1) NO875359L (fr)
NZ (1) NZ223026A (fr)
PT (1) PT86455B (fr)
SA (1) SA90110074B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (fr) * 1987-03-17 1990-10-10 FISONS plc Nédocromil pour le traitement des maladies dermatologiques
GB8727590D0 (en) * 1987-11-25 1987-12-31 Fisons Plc Formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
RU2576033C2 (ru) * 2009-12-03 2016-02-27 Опко Хелс, Инк. Составы на основе гиперсулфатированных дисахаридов

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474787A (en) * 1977-05-04 1984-10-02 Fisons Limited 7,6 Dioxo-4H,6H-pyrano[3,2-g]quinoline dicarboxylic acids and anti-allergic use thereof
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them
ZA782473B (en) * 1977-05-04 1979-04-25 Fisons Ltd Benzo pyrano-quinolinones
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
ATE11774T1 (de) * 1979-12-07 1985-02-15 Fisons Plc Verfahren zur herstellung von 1,4-dihydro-4-oxo- chinolin-2-carbonsaeuren oder salzen, estern oder amiden davon und zwischenverbindungen dafuer.
AU8468782A (en) * 1981-06-25 1983-01-06 Fisons Plc Compounds with sodium cromoglycate activity
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (fr) * 1984-04-13 1991-11-06 FISONS plc Formes et formulations des sels de sodium de nédocromil
GB8630419D0 (en) * 1986-12-19 1987-01-28 Fisons Plc Pharmaceutical formulation
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
GB8704773D0 (en) * 1987-02-28 1987-04-01 Fisons Plc Compounds
EP0294914A3 (fr) * 1987-03-17 1990-10-10 FISONS plc Nédocromil pour le traitement des maladies dermatologiques

Also Published As

Publication number Publication date
DK680787A (da) 1988-06-24
JP2504926B2 (ja) 1996-06-05
MY101535A (en) 1991-11-30
EP0279121A3 (en) 1990-09-12
PT86455A (en) 1988-01-01
IE940371L (en) 1988-06-23
KR960001370B1 (ko) 1996-01-26
CA1296635C (fr) 1992-03-03
FR2609392B1 (fr) 1994-04-08
ES2058129T3 (es) 1994-11-01
CH674937A5 (fr) 1990-08-15
JPS63233918A (ja) 1988-09-29
BE1002179A5 (fr) 1990-10-02
FI875616A0 (fi) 1987-12-21
PT86455B (pt) 1990-11-20
GR871999B (en) 1988-04-26
NO875359L (no) 1988-06-24
EP0279121B1 (fr) 1993-09-01
US5443833A (en) 1995-08-22
BE1003466A3 (fr) 1992-03-31
DE3787274D1 (de) 1993-10-07
SA90110074B1 (ar) 2006-03-06
AU8292987A (en) 1988-06-23
NO875359D0 (no) 1987-12-21
FR2609392A1 (fr) 1988-07-15
DE3787274T2 (de) 1994-01-27
IL84893A (en) 1991-11-21
JP2568233B2 (ja) 1996-12-25
IE873507L (en) 1988-06-23
DK680787D0 (da) 1987-12-22
KR880007082A (ko) 1988-08-26
IL84893A0 (en) 1988-06-30
AU595969B2 (en) 1990-04-12
IE63213B1 (en) 1995-04-05
FI875616A (fi) 1988-06-24
JPH07231926A (ja) 1995-09-05
NZ223026A (en) 1989-09-27
LU87087A1 (fr) 1989-07-07
EP0279121A2 (fr) 1988-08-24
IE940372L (en) 1988-06-23

Similar Documents

Publication Publication Date Title
EP0734249B1 (fr) Nouvelle formulation amelioree d'aminoglucoside pour administration sous forme d'aerosol
CN107847604B (zh) 眼用原位凝胶处方
US20100297034A1 (en) Osmolyte-containing preparation for use in case of dry mucous membranes
CN107753424A (zh) 一种不含防腐剂的多剂量包装抗炎滴眼液及其制备方法
CN110869023B (zh) 原位凝胶形成药物组合物及其在鼻窦疾病中的应用
JPH1160505A (ja) 防腐組成物
JPH085800B2 (ja) 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
DK2766008T3 (en) PHARMACEUTICAL COMPOSITION FOR NASAL APPLICATION WITH IMPROVED STABILITY
DK175032B1 (da) Farmaceutiske præparater omfattende en vandig opløsning af et pyranoquinolinderivat
EP0345926B1 (fr) Compositions pharmaceutiques contenant de la pentamidine
TW200902093A (en) N-halogenated amino acid formulations
JPH02196716A (ja) 薬学的溶液
JP5258329B2 (ja) プラノプロフェン含有水性医薬組成物
US20100204181A1 (en) N-halogenated amino acid formulations comprising phosphine or amine oxides
USRE38628E1 (en) Pharmaceutical compositions
JP2014098037A (ja) Ｎ−ハロゲン化アミノ酸処方物を含む脂肪族系酸
EP0555717A1 (fr) Compositions pharmaceutiques en forme de solutions contenant du nédocromil
CN105939720B (zh) 有效对抗病毒性结膜炎的组合物
EA030042B1 (ru) Комбинированное терапевтическое средство для лечения ринита
JP2842689B2 (ja) 水溶性イボパミン酸付加塩を含有する眼薬
EP0082546B2 (fr) Mélange pharmaceutique et procédé d'obtention du mélange
EP0555718A1 (fr) Compositions pharmaceutiques en forme d'ampoules douces en plastique contenant une solution de nédocromil
US5093348A (en) Pharmaceutical composition for topical ophthalmic use having improved local tolerability
CN115300502A (zh) 褪黑素在制备预防、治疗眼部近视的药物中的用途及其剂型和制备方法

Legal Events

Date Code Title Description
PUP Patent expired